Description
Product Overview: Sofovir is a potent antiviral medication containing 400mg of Sofosbuvir per tablet, manufactured by Hetero Healthcare Ltd. Sofosbuvir, the active ingredient in Sofovir, is a nucleotide analog inhibitor of the hepatitis C virus (HCV) polymerase enzyme, essential for the replication of the virus. Sofovir, under its international trade name Sovaldi, is widely recognized for its efficacy in the treatment of chronic hepatitis C infection.
Key Features:
- Active Ingredient: Sofovir contains Sofosbuvir, a direct-acting antiviral agent that targets the hepatitis C virus at its source, inhibiting viral replication and reducing viral load in the body.
- Strength: Each tablet of Sofovir comprises 400mg of Sofosbuvir, ensuring a standardized dosage for effective treatment of hepatitis C infection.
- International Trade Name: Sofovir is marketed internationally under the trade name Sovaldi, a well-established brand known for its efficacy and safety in hepatitis C treatment.
- Manufactured by Hetero Healthcare Ltd.: Sofovir is manufactured under stringent quality control measures by Hetero Healthcare Ltd., a leading pharmaceutical company committed to providing high-quality and affordable healthcare solutions.
Indications: Sofovir (Sovaldi) is indicated for the treatment of chronic hepatitis C infection in adults, either in combination with other antiviral medications or as part of a combination therapy regimen, as determined by a healthcare professional. It is effective against various genotypes of the hepatitis C virus.
Administration: Sofovir tablets are typically taken orally, with or without food, as directed by a healthcare provider. The recommended dosage and duration of treatment may vary depending on factors such as the patient’s hepatitis C genotype, treatment history, and overall health status.
Storage: Sofovir tablets should be stored at room temperature, away from moisture and heat, in a tightly closed container. It is essential to follow the storage instructions provided by the manufacturer to ensure the stability and potency of the medication.
Precautions:
- Prior to initiating Sofovir therapy, patients should undergo thorough evaluation, including assessment of liver function, hepatitis C genotype, and any potential drug interactions.
- Sofovir should be used with caution in patients with pre-existing liver or kidney conditions, as dosage adjustments may be necessary.
- Patients should be monitored regularly during Sofovir treatment for any signs of adverse reactions or changes in liver function tests.
Adverse Reactions: Common adverse reactions associated with Sofovir may include fatigue, headache, nausea, insomnia, and diarrhea. Serious side effects such as liver toxicity or reactivation of hepatitis B virus may occur in some cases. Patients should report any unusual symptoms to their healthcare provider promptly.
Disclaimer: This description provides general information about Sofovir 400mg Tablets (Sovaldi) manufactured by Hetero Healthcare Ltd. It is not intended to replace professional medical advice or serve as a comprehensive guide. Patients should consult their healthcare provider for personalized guidance regarding the use of Sofovir or any other medication.
Reviews
There are no reviews yet.